Esber A, Dear N, Shah N, Kibuuka H, et al. Virologic impact of the dolutegravir transition: prospective results from the multinational African Cohort Study. J Acquir Immune Defic Syndr 2022 Aug 3. pii: 00126334-990000000-00084.
PMID: 35980350